tirzepatide off fda shortage list 🚨 Alert: No Longer on FDA's Drug As of October 2, 2024, the has announced that the Tirzepatide shortage has been resolved. This means that all doses of GLP-1 No Longer on FDA's

The platform may, at its discretion, issue refunds for partially used subscription periods on a case-by-case basis, but this is not guaranteed

Ask your PlexusDx provider before using any topical treatment to ensure it won't interfere with your therapy

Niacinamide plays an important role in our body, including: Skin health: It is frequently used in topical skin care products for its anti-inflammatory and barrier-strengthening properties

A standard protocol typically starts at 2.5 mg per week, increasing to 5 mg per week after 4 weeks

Short-term room-temperature exposure within manufacturer guidelines is acceptable

Women of reproductive age are disproportionately impacted, and obesity is strongly associated with infertility, pregnancy complications, and adverse neonatal outcomes, often mediated by metabolic disorders such as type 2 diabetes mellitus (T2DM) and polycystic ovary syndrome (PCOS) [1,2,3,4]